Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical cash
Cash and short-term investments held at the end of each period.
Rockwell Medical's cash was $24.80M at Jun 30, 2026. For fiscal 2025 it was $25.00M, up 15.7% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $65.80M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.00M | +15.7% |
| FY2024 | Dec 31, 2024 | $21.60M | +98.2% |
| FY2023 | Dec 31, 2023 | $10.90M | -49.3% |
| FY2022 | Dec 31, 2022 | $21.50M | -4.0% |
| FY2021 | Dec 31, 2021 | $22.40M | -61.8% |
| FY2020 | Dec 31, 2020 | $58.70M | +125.4% |
| FY2019 | Dec 31, 2019 | $26.05M | -22.3% |
| FY2018 | Dec 31, 2018 | $33.53M | +298.9% |
| FY2017 | Dec 31, 2017 | $8.41M | -51.1% |
| FY2016 | Dec 31, 2016 | $17.18M | -44.9% |
| FY2015 | Dec 31, 2015 | $31.20M | -52.6% |
| FY2014 | Dec 31, 2014 | $65.80M | +453.8% |
| FY2013 | Dec 31, 2013 | $11.88M | +152.2% |
| FY2012 | Dec 31, 2012 | $4.71M | -17.6% |
| FY2011 | Dec 31, 2011 | $5.72M | -53.4% |
| FY2010 | Dec 31, 2010 | $12.26M | -46.8% |
| FY2009 | Dec 31, 2009 | $23.04M | +311.6% |
| FY2008 | Dec 31, 2008 | $5.60M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.80M | +34.8% |
| Q1 FY2026 | Mar 31, 2026 | $23.90M | +38.2% |
| Q4 FY2025 | Dec 31, 2025 | $25.00M | +15.7% |
| Q3 FY2025 | Sep 30, 2025 | $23.70M | +29.5% |
| Q2 FY2025 | Jun 30, 2025 | $18.40M | +54.6% |
| Q1 FY2025 | Mar 31, 2025 | $17.30M | +101.2% |
| Q4 FY2024 | Dec 31, 2024 | $21.60M | +98.2% |
| Q3 FY2024 | Sep 30, 2024 | $18.30M | +56.4% |
| Q2 FY2024 | Jun 30, 2024 | $11.90M | -20.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.60M | -48.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.90M | -49.3% |
| Q3 FY2023 | Sep 30, 2023 | $11.70M | -57.6% |
| Q2 FY2023 | Jun 30, 2023 | $14.90M | -51.6% |
| Q1 FY2023 | Mar 31, 2023 | $16.80M | +69.5% |
| Q4 FY2022 | Dec 31, 2022 | $21.50M | -4.0% |
| Q3 FY2022 | Sep 30, 2022 | $27.60M | -16.9% |
| Q2 FY2022 | Jun 30, 2022 | $30.78M | -24.9% |
| Q1 FY2022 | Mar 31, 2022 | $9.91M | -78.5% |
| Q4 FY2021 | Dec 31, 2021 | $22.40M | -61.8% |
| Q3 FY2021 | Sep 30, 2021 | $33.20M | -50.7% |
| Q2 FY2021 | Jun 30, 2021 | $41.00M | +2.6% |
| Q1 FY2021 | Mar 31, 2021 | $46.10M | -5.6% |
| Q4 FY2020 | Dec 31, 2020 | $58.70M | +125.4% |
| Q3 FY2020 | Sep 30, 2020 | $67.32M | +366.8% |
| Q2 FY2020 | Jun 30, 2020 | $39.96M | +86.6% |
| Q1 FY2020 | Mar 31, 2020 | $48.86M | +133.5% |
| Q4 FY2019 | Dec 31, 2019 | $26.05M | -22.3% |
| Q3 FY2019 | Sep 30, 2019 | $14.42M | +236.0% |
| Q2 FY2019 | Jun 30, 2019 | $21.42M | +1125.1% |
| Q1 FY2019 | Mar 31, 2019 | $20.92M | +538.2% |
| Q4 FY2018 | Dec 31, 2018 | $33.53M | +298.9% |
| Q3 FY2018 | Sep 30, 2018 | $4.29M | +10.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.75M | -79.3% |
| Q1 FY2018 | Mar 31, 2018 | $3.28M | -72.6% |
| Q4 FY2017 | Dec 31, 2017 | $8.41M | -51.1% |
| Q3 FY2017 | Sep 30, 2017 | $3.89M | -79.8% |
| Q2 FY2017 | Jun 30, 2017 | $8.46M | – |
| Q1 FY2017 | Mar 31, 2017 | $11.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.18M | – |
| Q3 FY2016 | Sep 30, 2016 | $19.29M | – |
See a number that looks wrong?